In 2024, Dr. Han Ying earned $384.74K in total compensation at Gyre Therapeutics, Inc., including $338.61K salary and $35.00K bonus. Led Gyre Therapeutics, Inc. as CEO for 1 years.
Compensation History
Annual executive compensation data for Dr. Han Ying, including salary, bonuses, and stock awards.
Year
2024
Total Compensation
$384.74K
Salary
$338.61K
Bonus
$35.00K
Other
$11.13K
Salary
$338.61KBoard Justification
These elements (and the amounts of compensation and benefits under each element) were selected because the Company believes they are necessary to help attract and retain executive talent which is fundamental to its success.
Bonus
$35.00KBoard Justification
Mr. Ying was eligible to earn annual cash bonuses targeted at 10% of their respective base salaries. The Compensation Committee approved annual bonuses for Mr. Ying in the amount of $35,000.
Other Compensation
$11.13KBoard Justification
a $2,625 cash retainer for his Board service during 2024 prior to being appointed the Company’s Chief Executive Officer and a Company contribution of $8,500 to Dr. Ying’s account under the Company’s 401(k) plan
Restricted Stock
Board Justification
No vested stock was reported for Dr. Ying in 2024.
Performance Metrics
Such awards are designed to incentivize the named executive officers with a variable level of compensation that is based on performance measures established by the Company’s Compensation Committee that are tied to pre-defined business and personal goals and objectives.
Dr. Han Ying
Founder and Ex-CEO of Gyre Therapeutics, Inc.
Education
Ph.D. in Cancer Biology from Stanford University; B.S. and M.S. in Biological Studies from Beijing University.
Field of Expertise
Healthcare & Life Sciences - Immunology
Sector of Economy
Healthcare
Born
January 1, 1964 - 61 years ago
CEO of Gyre Therapeutics, Inc. for
1 year 6 months (Jan 2024 - Aug 2025)
Previous Experience
Director at Gene Corporation; Co-founder and Chief Operating Officer at Base Therapeutics; Chief Technology Officer at Tactiva Therapeutics; Principal Investigator at Maxine Dunitz Neurosurgical Institute.
Other Gyre Therapeutics, Inc. CEOs
Holdings
Track Dr. Han Ying's stock holdings and portfolio value over time.
Insider Trading
Dr. Han Ying's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Dr. Han Ying with competitor CEOs and industry peers.